NCT06663878View on ClinicalTrials.gov

An Exploratory Study to Evaluate the Tolerability and Safety of MWAV201 in Subjects With Wilson Disease

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

May 31, 2031

Conditions

Wilson Disease

Interventions

GENETIC

MWAV201

Nonreplicating, recombinant gene transfer vector

Trial Locations (1)

200092

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors

collaborator

Mabwell (Shanghai) Bioscience Co., Ltd.

INDUSTRY

lead

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

NCT06663878 - An Exploratory Study to Evaluate the Tolerability and Safety of MWAV201 in Subjects With Wilson Disease | Biotech Hunter | Biotech Hunter